Article
Rationally designed Mycoplasma gallisepticum vaccine using a recombinant subunit approach
28 Sept 2024
Abstract excerpt
Mycoplasma gallisepticum (MG) is an avian respiratory pathogen causing significant global economic losses to the poultry industries. Current live-attenuated and bacterin vaccines provide some measures of protective immunity but exhibit suboptimal efficacy, utility, or safety. To address these shortcomings, we utilized knowledge of MG biology and virulence to develop a subunit vaccine containing recombinantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
